Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
The Alendronate Discontinuation Study
NCT06864130Phase 4Recruiting
- Sponsor
- University Hospital Odense
- Start
- Feb 2025
- Primary completion
- Mar 2029
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, single-blind trial of alendronate in osteoporosis (2 arms), sponsored by University Hospital Odense. Primary endpoint: Fragility fractures at 3 years. Started Feb 2025; status: recruiting.
02
Drugs
alendronate
03
Conditions
osteoporosis
Beyond the preview
Go deeper on NCT06864130.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06864130.